Fidelity, Sanofi back $75M round for Jeremy Levin’s neurology startup
Jeremy Levin has stepped up with a $75 million round to back Phase II work on Ovid Therapeutics’ lead drug for rare brain diseases as the ex-Teva chief executes on his plan to build a pipeline of experimental drugs in neurology.
Source: <a target='_blank' href='http://www.fiercebiotech why not try this out.com/story/fidelity-sanofi-back-75m-round-jeremy-levins-neurology-startup/2015-08-11′>www.fiercebiotech.com